AJP - Endocrinology and Metabolism, Vol 269, Issue 6 E1037-E1043, Copyright © 1995 by American Physiological Society

ARTICLES

Quantitation of hepatic glucose fluxes and pathways of hepatic glycogen synthesis in conscious mice

D. Massillon, W. Chen, M. Hawkins, R. Liu, N. Barzilai and L. Rossetti
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Mice were studied with the euglycemic hyperinsulinemic and the hyperglycemic clamp techniques after a 6-h fast: 1) euglycemic (6.7 +/- 0.2 mM) hyperinsulinemia (approximately 800 microU/ml); 2) hyperglycemic (15.3 +/- 0.4 mM) hyperinsulinemia (approximately 800 microU/ml). All mice received an infusion of [3-3H]glucose and [U-14C]lactate. Basal hepatic glucose production (HGP) averaged approximately 170 mumol.kg-1.min-1 in both groups. During euglycemic and hyperglycemic hyperinsulinemia, HGP decreased by 53% (to 76.7 +/- 11.1 mumol.kg-1.min-1; P < 0.01) and 74% (to 43.3 +/- 7.2 mumol.kg-1.min-1; P < 0.01), respectively. Hyperglycemia increased glucose cycling (by 2.1-fold; P < 0.01) and the contribution of gluconeogenesis to HGP (88 vs. 43%; P < 0.01) while decreasing that of glycogenolysis (12 vs. 57%; P < 0.01). The percentage of neosynthetized hepatic glycogen formed via the direct pathway was markedly increased during hyperglycemia (53 +/- 2% vs. 23 +/- 3%; P < 0.01): These data indicate that the assessment of hepatic glucose fluxes can be accomplished in conscious unrestrained mice and that, in the presence of hyperinsulinemia, hyperglycemia causes 1) a further inhibition of HGP mainly via inhibition of glycogenolysis and increase in hepatic glucose cycling; and 2) about a fivefold stimulation in the direct pathway of hepatic glycogen formation.

This article has been cited by other articles:

				C. Wu, S. A. Khan, L.-J. Peng, H. Li, S. G. Carmella, and A. J. Lange Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E536 - E543. [Abstract] [Full Text] [PDF]

				E. Carvalho, K. Kotani, O. D. Peroni, and B. B. Kahn Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E551 - E561. [Abstract] [Full Text] [PDF]

				S. T. Mathews, G. P. Singh, M. Ranalletta, V. J. Cintron, X. Qiang, A. S. Goustin, K.-L. C. Jen, M. J. Charron, W. Jahnen-Dechent, and G. Grunberger Improved Insulin Sensitivity and Resistance to Weight Gain in Mice Null for the Ahsg Gene Diabetes, August 1, 2002; 51(8): 2450 - 2458. [Abstract] [Full Text] [PDF]

				C. Arizmendi, S. Liu, C. Croniger, V. Poli, and J. E. Friedman The Transcription Factor CCAAT/Enhancer-binding Protein beta  Regulates Gluconeogenesis and Phosphoenolpyruvate Carboxykinase (GTP) Gene Transcription during Diabetes J. Biol. Chem., May 7, 1999; 274(19): 13033 - 13040. [Abstract] [Full Text] [PDF]

				L. Rossetti, W. Chen, M. Hu, M. Hawkins, N. Barzilai, and S. Efrat Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E743 - E750. [Abstract] [Full Text] [PDF]